{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:15:53Z","timestamp":1791393353645,"version":"4.3.3"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin. Vaccine Immunol."],"published-print":{"date-parts":[[2015,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The transforming growth factor \u03b21\/interleukin-31 (TGF-\u03b21\/IL-31) pathway plays an important role in the process of cell injury and inflammation. The purpose of this work was to explore the role of the TGF-\u03b21\/IL-31 pathway in the cytopathic process of hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF). The quantitative serum levels of TGF-\u03b21, IL-9, IL-10, IL-17, IL-22, IL-23, IL-31, IL-33, and IL-35 were analyzed among chronic hepatitis B (CHB) patients (<jats:italic>n<\/jats:italic>= 17), ACLF patients (<jats:italic>n<\/jats:italic>= 18), and normal control (NC) subjects (<jats:italic>n<\/jats:italic>= 18). Disease severity in patients with ACLF was assessed using the model for end-stage liver disease (MELD) and Child-Pugh scores. Serum TGF-\u03b21 levels were strongly positively correlated with IL-31 in all subjects, and both of them were positively correlated with IL-17, IL-22, and IL-33. In CHB and ACLF patients, serum levels of TGF-\u03b21 and IL-31 were both increased significantly compared with those in NC subjects and positively correlated with total bilirubin (TBil) and alpha-fetoprotein (AFP) levels. ACLF patients showed the highest levels of TGF-\u03b21 and IL-31, which were positively correlated with Child-Pugh scores. Furthermore, the recovery from the liver injury in CHB was accompanied by decreased TGF-\u03b21 and IL-31 levels. More importantly, serum levels of TGF-\u03b21 and IL-31 were markedly upregulated in ACLF nonsurvivors, and IL-31 displayed the highest sensitivity and specificity (85.7% and 100.0%, respectively) in predicting nonsurvival of ACLF patients. Increasing activity of the TGF-\u03b21\/IL-31 pathway is well correlated with the extent of liver injury, disease severity, and nonsurvival of ACLF patients, while reducing activity is detected along the recovery from liver injury in CHB, suggesting its potential role in the pathogenesis of liver injury during chronic HBV infection.<\/jats:p>","DOI":"10.1128\/cvi.00649-14","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T17:40:48Z","timestamp":1424972448000},"page":"484-492","source":"Crossref","is-referenced-by-count":33,"title":["The Transforming Growth Factor \u03b21\/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival"],"prefix":"10.1128","volume":"22","author":[{"given":"Xueping","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desong","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","published-online":{"date-parts":[[2015,2,25]]},"reference":[{"key":"key20180919073801_B1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/MNH.0b013e3283309660","article-title":"Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm","volume":"18","year":"2009","journal-title":"Curr Opin Nephrol Hypertension"},{"key":"key20180919073801_B2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/0006-291X(87)91340-4","article-title":"Transforming growth factor beta inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver","volume":"145","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180919073801_B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08977199309029129","article-title":"Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta)","volume":"8","year":"1993","journal-title":"Growth Factors"},{"key":"key20180919073801_B4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S0168-8278(97)80313-3","article-title":"Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure","volume":"27","year":"1997","journal-title":"J Hepatol"},{"key":"key20180919073801_B5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1179\/096805105225006650","article-title":"Role of transforming growth factor-beta1 (TGF-beta1) in endotoxin-induced hepatic failure after extensive hepatectomy in rats","volume":"11","year":"2005","journal-title":"J Endotoxin Res"},{"key":"key20180919073801_B6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jaci.2005.10.033","article-title":"IL-31: a new link between T cells and pruritus in atopic skin inflammation","volume":"117","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"key20180919073801_B7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ejcb.2011.07.006","article-title":"Signaling by IL-31 and functional consequences","volume":"91","year":"2012","journal-title":"Eur J Cell Biol"},{"key":"key20180919073801_B8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pupt.2010.10.005","article-title":"STAT3 in tissue fibrosis: is there a role in the lung?","volume":"24","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"key":"key20180919073801_B9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jdermsci.2014.02.009","article-title":"Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis","volume":"74","year":"2014","journal-title":"J Dermatol Sci"},{"key":"key20180919073801_B10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jaci.2006.07.015","article-title":"Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis","volume":"118","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"key20180919073801_B11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jaci.2007.07.065","article-title":"A common haplotype of the IL-31 gene influencing gene expression is associated with nonatopic eczema","volume":"120","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"key20180919073801_B12","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1600-0625.2010.01067.x","article-title":"Increased levels of serum IL-31 in chronic spontaneous urticaria","volume":"19","year":"2010","journal-title":"Exp Dermatol"},{"key":"key20180919073801_B13","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-014-2913-x","article-title":"Role of IL-31 in regulation of Th2 cytokine levels in patients with nasal polyps","year":"2014","journal-title":"Eur Arch Oto-Rhino-Laryngo"},{"key":"key20180919073801_B14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4132\/KoreanJPathol.2012.46.2.162","article-title":"Identifying polymorphisms in IL-31 and their association with susceptibility to asthma","volume":"46","year":"2012","journal-title":"Korean J Pathol"},{"key":"key20180919073801_B15","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/jid.2012.484","article-title":"MCP-1 as an effector of IL-31 signaling in familial primary cutaneous amyloidosis","volume":"133","year":"2013","journal-title":"J Investig Dermatol"},{"key":"key20180919073801_B16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1378\/chest.125.2.754","article-title":"The role of transforming growth factor beta in lung development and disease","volume":"125","year":"2004","journal-title":"Chest"},{"key":"key20180919073801_B17","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/jcp.22295","article-title":"TGFbeta1 induces IL-6 and inhibits IL-8 release in human bronchial epithelial cells: the role of Smad2\/3","volume":"225","year":"2010","journal-title":"J Cell Physiol"},{"key":"key20180919073801_B18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.resp.2013.09.011","article-title":"Pathogenesis pathways of idiopathic pulmonary fibrosis in bleomycin-induced lung injury model in mice","volume":"190","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"key20180919073801_B19","first-page":"1","article-title":"Dynamic changes and effects of interleukin-31 and transforming growth factor beta 1 in lung tissues of experimental mice with pulmonary fibrosi","volume":"23","year":"2011","journal-title":"J Heze Med Col"},{"key":"key20180919073801_B20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1365-2893.2008.01046.x","article-title":"Prediction of the prognosis of patients with acute-on-chronic hepatitis B liver failure using the model for end-stage liver disease scoring system and a novel logistic regression model","volume":"16","year":"2009","journal-title":"J Viral Hepat"},{"key":"key20180919073801_B21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.4049\/jimmunol.177.1.739","article-title":"Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B","volume":"177","year":"2006","journal-title":"J Immunol"},{"key":"key20180919073801_B22","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1440-1746.2008.05484.x","article-title":"Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment","volume":"23","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180919073801_B23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.23273","article-title":"Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B","volume":"51","year":"2010","journal-title":"Hepatology"},{"key":"key20180919073801_B24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jhep.2008.05.017","article-title":"Severe dendritic cell perturbation is actively involved in the pathogenesis of acute-on-chronic hepatitis B liver failure","volume":"49","year":"2008","journal-title":"J Hepatol"},{"key":"key20180919073801_B25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/vim.2010.0135","article-title":"The ratio of Th-17 to Treg cells is associated with survival of patients with acute-on-chronic hepatitis B liver failure","volume":"24","year":"2011","journal-title":"Viral Immunol"},{"key":"key20180919073801_B26","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1477-7819-11-212","article-title":"Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy","volume":"11","year":"2013","journal-title":"World J Surg Oncol"},{"key":"key20180919073801_B27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","year":"1973","journal-title":"Br J Surg"},{"key":"key20180919073801_B28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2893.2011.01475.x","article-title":"Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease","volume":"18","year":"2011","journal-title":"J Viral Hepat"},{"key":"key20180919073801_B29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4049\/jimmunol.0900687","article-title":"Increased killing of liver NK cells by Fas\/Fas ligand and NKG2D\/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure","volume":"184","year":"2010","journal-title":"J Immunol"},{"key":"key20180919073801_B30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/MCG.0b013e3181624464","article-title":"Imbalanced intrahepatic cytokine expression of interferon-gamma, tumor necrosis factor-alpha, and interleukin-10 in patients with acute-on-chronic liver failure associated with hepatitis B virus infection","volume":"43","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"key20180919073801_B31","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/jgh.12459","article-title":"Ratios of regulatory T cells\/T-helper 17 cells and transforming growth factor-beta1\/interleukin-17 to be associated with the development of hepatitis B virus-associated liver cirrhosis","volume":"29","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180919073801_B32","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/hep.26916","article-title":"Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment","volume":"59","year":"2014","journal-title":"Hepatology"},{"key":"key20180919073801_B33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/jir.2011.0109","article-title":"Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis B","volume":"32","year":"2012","journal-title":"J Interferon Cytokine Res"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1128\/CVI.00649-14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T16:01:24Z","timestamp":1589385684000},"score":1,"resource":{"primary":{"URL":"https:\/\/cvi.asm.org\/content\/22\/5\/484"}},"subtitle":[],"editor":[{"given":"R. L.","family":"Hodinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,25]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,4,28]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.1128\/CVI.00649-14"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00649-14","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,25]]}}}